Compare · 2 funds side by side · dividends reinvested

IBB and XBI

IBBiShares×XBISPDR×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$13,634IBB · best of the two

02 / 04

IBB and XBI, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

iShares Biotechnology ETFSectors · Technology0.44%0.16%+27.8%+35.5%+24.5%+6.4%−9.6%22.7%$11.2B1.5

State Street SPDR S&P Biotech ETFSectors · Health care0.35%0.35%+27.2%+38.1%+34.5%+4.7%−14.9%29.1%$10.5B1.5

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: IBB 2001 · XBI 2006

Head to Head

Swap sides Versus in desk

Head to Head

iShares Biotechnology ETF · $11.2B$13,634

IBB

XBI

State Street SPDR S&P Biotech ETF · $10.5B$12,576

$10,000 five years ago, dividends reinvested · they hold 43.0% in common

IBBMeasureXBI

+27.8%Year to dateJan 1 → Nov 3+27.2%

+35.5%1 yearTotal return+38.1%

+24.5%3 years · per year$10,000 became $19,307 · $24,320+34.5%

+6.4%5 years · per year$10,000 became $13,634 · $12,576+4.7%

0.44%Expense ratio$44 · $35 a year on $10k · lower is better0.35%

0.16%Trailing 12-mo yield$16 · $35 a year on $10k0.35%

−9.6%Worst dropSmaller is better−14.9%

22.7%VolatilityLower is calmer29.1%

IBBXBI Winner of the row, in its colourEach row: the bigger of the two fills its side

4–4Level

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

IBB vs XBI: Top 5 Holdings

Today

IBB

36.8%in top 5

XBI

in top 59.7%

IBBStockXBI

8.9%GILDnot top 5

8.3%AMGNnot top 5

7.9%VRTXnot top 5

6.2%REGNnot top 5

5.5%MRNA2.4%

not top 5TWST2.0%

not top 5NTRA1.9%

not top 5HALO1.8%

not top 5BIIB1.7%

Held in common43.0%

End-of-day Nov 3, 2026 · share of each fund

IBB vs XBI Returns, Every Period

iSharesIBB

+6.4%

5 years, per year

XBISPDR

+4.7%

5 years, per year

IBBXBIFaded: behind in that period

2–2Level

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

IBB vs XBI

YTD

iSharesIBB

+27.8%

XBISPDR

+27.2%

+27.8%Year to date+27.2%

−9.6%Worst drop · 1Y−14.9%

22.7%Volatility · 1Y29.1%

0.2%Yield0.4%

$11.2BAssets$10.5B

3–1IBB wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: IBB, XBI

Today

0.35%lowest, XBI

FundExpense ratioFee$10k

XBI0.35%$35

IBB0.44%$44

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: IBB, XBI

0.35%highest, XBI

FundTrailing yieldYield$10k

XBI0.35%$35

IBB0.16%$16

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$0most kept, XBI

XBI$35 − $35 = $0

IBB$16 − $44 = −$28

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: IBB, XBI

Today

43.0%most shared, IBB and XBI

IBBXBI

IBB—43.0%

XBI43.0%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+38.1%XBI, at 29.1% volatility

IBBWorst drop−9.6%22.7% vol

XBIWorst drop−14.9%29.1% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

XBIIBB

+27.2%Year to date+27.8%

0.4%Yield0.2%

+38.1%Past year+35.5%

0.35%Fee0.44%

3–1XBI wins

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026